TickerFiles

BIOLARGO, INC. 10-Q filing

Filed 2025-11-14 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001437749-25-035239
Form type
10-Q
CIK
0000880242
Primary document
https://www.sec.gov/Archives/edgar/data/880242/000143774925035239/blgo20250930_10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BIOLARGO, INC..

Reported financial metrics

MetricCurrentPriorChange
Cost Of Revenue$3.9M--
Gross Profit$3.3M--
Operating Income$-10.8M--
Eps Basic-0.03--
Cash And Equivalents$4.5M--
Total Assets$9.1M--
Total Liabilities$5.9M--
Shareholders Equity$6.6M--
Operating Cash Flow$-6.7M--